Center of Surgical Infection Research and Therapeutics, Department of Surgery, Pritzker School of Medicine, University of Chicago, Chicago, IL 60637, USA.
Ann Surg. 2012 Feb;255(2):386-93. doi: 10.1097/SLA.0b013e3182331870.
This study was designed to examine the effect of morphine administration on the intestinal mucus barrier and determine its direct effect on the virulence and lethality of Pseudomonas aeruginosa, one of the most frequent pathogens to colonize the gut of critically ill patients.
Surgical injury is associated with significant exposure of host tissues to morphine from both endogenous release and its use as a potent analgesic agent. Morphine use in surgical patients exposed to extreme physiologic stress is well established to result in increased infection risk. Although morphine is a known immunosuppressant, whether it directly induces virulence expression and lethality in microbes that colonize the human gut remains unknown.
Mice were implanted with a slow release morphine or placebo pellet with and without intestinal inoculation of P. aeruginosa created by direct cecal injection. Mucus production and epithelial integrity was assessed in cecal tissue via Alcian blue staining and histologic analysis. In vivo and in vitro P. aeruginosa virulence expression was examined using reporter strains tagged to the epithelial barrier disrupting protein PA-I lectin. P. aeruginosa chemotaxis toward morphine was also assayed in vitro. Finally, the direct effect of morphine to induce PA-I lectin expression was determined in the absence and presence of methylnaltrexone, a μ opioid receptor antagonist.
Mice intestinally inoculated with P. aeruginosa and implanted with a morphine pellet demonstrated significant suppression of intestinal mucus, disrupted intestinal epithelium, and enhanced mortality; whereas exposure of mice to either systemic morphine or intestinal P. aeruginosa alone enhanced intestinal mucus without mortality, suggesting a shift in P. aeruginosa during morphine exposure to a mucus suppressing, barrier disrupting, and lethal phenotype. Direct exposure of P. aeruginosa to morphine in vitro confirmed that morphine can transform P. aeruginosa to a more virulent phenotype that is attenuated in part by methylnaltrexone.
Morphine administration shifts intestinal P. aeruginosa to express a virulent phenotype and may play a role in its ability to causes lethal gut-derived sepsis in a susceptible host.
本研究旨在探讨吗啡给药对肠道黏液屏障的影响,并确定其对铜绿假单胞菌毒力和致死率的直接影响。铜绿假单胞菌是定植于危重病患者肠道的最常见病原体之一。
手术损伤会导致宿主组织大量暴露于内源性释放和作为强效镇痛剂的吗啡。在暴露于极端生理应激的手术患者中使用吗啡已被证实会增加感染风险。尽管吗啡是一种已知的免疫抑制剂,但它是否直接诱导定植于人体肠道的微生物表达毒力和致死性仍不清楚。
通过直接盲肠注射,在植入缓释吗啡或安慰剂微球的小鼠和未植入的小鼠中进行肠道铜绿假单胞菌接种。通过对盲肠组织进行阿利新蓝染色和组织学分析,评估黏液生成和上皮完整性。使用标记上皮屏障破坏蛋白 PA-I 凝集素的报告菌株,检测体内和体外铜绿假单胞菌的毒力表达。还在体外检测了铜绿假单胞菌对吗啡的趋化性。最后,在不存在和存在甲基纳曲酮(μ 阿片受体拮抗剂)的情况下,确定吗啡诱导 PA-I 凝集素表达的直接作用。
盲肠接种铜绿假单胞菌并植入吗啡微球的小鼠表现出明显的肠道黏液抑制、肠道上皮破坏和死亡率增加;而暴露于系统吗啡或单独肠道铜绿假单胞菌的小鼠则增强了肠道黏液而没有死亡,表明在吗啡暴露期间,铜绿假单胞菌向黏液抑制、屏障破坏和致死表型发生了转变。体外直接暴露于吗啡的铜绿假单胞菌证实,吗啡可以将铜绿假单胞菌转化为更具毒力的表型,这种表型在一定程度上可以被甲基纳曲酮减弱。
吗啡给药会使肠道铜绿假单胞菌表达一种毒力表型,并可能在其导致易感宿主致命性肠道来源败血症的能力中发挥作用。